iANTHUS CAPITAL HOLDINGS (ITHUF) Enterprise Value (2020 - 2026)
iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly Enterprise Value came in at -$11.2 million in Q1 2026, up 55.27% year-on-year from -$7.2 million in Q1 2025, and up 5.56% quarter-over-quarter from -$11.9 million in Q4 2025.
iANTHUS CAPITAL HOLDINGS (ITHUF) Enterprise Value (2020 - 2026) Analysis & Trends
iANTHUS CAPITAL HOLDINGS has disclosed Enterprise Value across 7 years of filings, most recently posting -$11.2 million for Q1 2026.
- Enterprise Value for Q1 2026 came in at -$11.2 million, up 55.27% year-over-year; the trailing twelve-month figure through Mar 2026 was -$11.2 million (up 55.27% YoY), and the FY2025 annual result was -$11.9 million, up 37.85% from the prior year.
- Enterprise Value came in at -$11.2 million for Q1 2026 at iANTHUS CAPITAL HOLDINGS, up from -$11.9 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$70000.0 in Q3 2022 to a low of -$25.1 million in Q1 2025.
- The 5-year median for Enterprise Value is -$12.4 million (2023), against an average of -$12.0 million.
- Across the five-year window, Enterprise Value surged 98.31% in 2022 and slumped 21577.14% in 2023, its largest moves.
- iANTHUS CAPITAL HOLDINGS's Enterprise Value stood at -$100000.0 in 2022, then slumped by 650.0% to -$750000.0 in 2023, then tumbled by 2446.53% to -$19.1 million in 2024, then soared by 37.85% to -$11.9 million in 2025, then increased by 5.56% to -$11.2 million in 2026.
- The last three Enterprise Value figures came in at -$11.2 million (Q1 2026), -$11.9 million (Q4 2025), and -$17.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -3.74 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -1.94 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -2.15 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -77.77 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -1.32 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -428.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -511.86 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -750.88 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -498.58 Mn |
| 10 | iANTHUS CAPITAL HOLDINGS | - | - | 15.92 Mn | -11.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.21 Mn |
| Dec 31, 2025 | -11.87 Mn |
| Sep 30, 2025 | -17.93 Mn |
| Jun 30, 2025 | -23.94 Mn |
| Mar 31, 2025 | -25.06 Mn |
| Dec 31, 2024 | -19.10 Mn |
| Sep 30, 2024 | -20.86 Mn |
| Jun 30, 2024 | -16.94 Mn |
| Mar 31, 2024 | -13.73 Mn |
| Dec 31, 2023 | -750,000.00 |
| Sep 30, 2023 | -15.17 Mn |
| Jun 30, 2023 | -10.14 Mn |
| Mar 31, 2023 | -12.37 Mn |
| Dec 31, 2022 | -100,000.00 |
| Sep 30, 2022 | -70,000.00 |
| Jun 30, 2022 | -1.34 Mn |
| Mar 31, 2022 | -2.64 Mn |
| Dec 31, 2021 | -3.90 Mn |
| Sep 30, 2021 | -4.14 Mn |
| Jun 30, 2021 | -5.71 Mn |